Reuters
Novo Nordisk's oral diabetes drug cuts heart-related risks by 14% in study
By Reuters,
4 days agoRelated Search
Novo NordiskDiabetes managementType 2 diabetesNovo Nordisk studiesCardiovascular healthAnil D'SilvaComments /
Add a Comment
YOU MAY ALSO LIKE
Reuters2 days ago
healio.com4 days ago
Northern Kentucky Tribune8 days ago
Reuters2 days ago
The Current GAlast hour
Jacksonville Today15 days ago
Northern Kentucky Tribune19 days ago
Reuters1 day ago
Uncovering Florida28 days ago
The HD Post6 days ago
Tysonomo Multimedia8 hours ago
Dianna Carney11 days ago
The Lantern9 days ago
Reuters1 day ago
The HD Post24 days ago
Northern Kentucky Tribune5 days ago
Florida Bulldog1 day ago
Dianna Carney8 days ago
The Shenandoah (PA) Sentinel17 hours ago
The HD Post24 days ago
Northern Kentucky Tribune10 days ago
David Heitz12 days ago
Get updates delivered to you daily. Free and customizable.
It’s essential to note our commitment to transparency:
Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. As a platform hosting over 100,000 pieces of content published daily, we cannot pre-vet content, but we strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation.
Comments / 0